Latest News about FDA
Recent news which mentions FDA
Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal
June 05, 2024
From Benzinga
From Benzinga
From Benzinga
FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates
June 04, 2024
Tickers
NEWS
From Benzinga
MDMA Therapy For PTSD Closer To Legality As Key FDA Approval Meeting Approaches, Sparking Hope And Controversy
June 03, 2024
Tickers
NEWS
From Benzinga
Why Microbot Medical Stock Is Up
June 03, 2024
From Benzinga
From Benzinga
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
May 31, 2024
From Benzinga
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
May 31, 2024
From Benzinga
From Prohibition To Protection: Could Marijuana's Reclassification Unleash A Surge In Trademark Filings?
May 30, 2024
From Benzinga
FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
May 29, 2024
From Benzinga
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
May 29, 2024
Tickers
NEWS
From Benzinga
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
May 29, 2024
From Benzinga
California's Famous Cannabis Goes To Europe: Rescheduling Drives Demand For De-Risked, Pest-Free, Low-Cost Plants
May 28, 2024
Tickers
NEWS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.